Faculty Disclosures
| Chelsea S. Kidwell, MD |
No disclosure on file
|
| Barry D. Jordan, MD |
Dr. Jordan has nothing to disclose. |
| Gretchen L. Birbeck, MD, MPH, DTMH, FAAN |
An immediate family member of Dr. Birbeck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Birbeck has a non-compensated relationship as a Ambassador for Zambia with RSTMH that is relevant to AAN interests or activities. |
| Ronald C. Petersen, MD, PhD, FAAN |
Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities. |
| Joseph Jankovic, MD, FAAN |
Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie. |
| Jeffrey L. Cummings, MD, FAAN |
Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia, Actinogen, Acumen, AlphaCognition, ALZpath, Aprinoia, AriBio, Artery, Biogen, Biohaven, BioVie, BioXcel, Bristol-Myers Squib, Cassava, Cerecin, Diadem, Eisai, GAP Foundation, GemVax, Janssen, Jocasta, Karuna, Lighthouse, Lilly, Lundbeck, LSP/eqt, Mangrove Therapeutics, Merck, NervGen, New Amsterdam, Novo Nordisk, Oligomerix, ONO, Optoceutics, Otsuka, Oxford Brain Diagnostics, Prothena, ReMYND, Roche, Sage Therapeutics, Signant Health, Simcere, sinaptica, Suven, TrueBinding, Vaxxinity, and Wren pharmaceutical, assessment, and investment companies. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia, Biogen, Genentech, Grifols, Janssen, Karuna, Otsuka, reMYND, Roche, Signant Health. Dr. Cummings has stock in Artery, Vaxxinity, Behrens, Alzheon, MedAvante-Prophase, and Acumen. Dr. Cummings has received research support from NIH. Dr. Cummings has received research support from NIGMS. Dr. Cummings has received intellectual property interests from a discovery or technology relating to health care. |
| Elliot M. Frohman, MD, FAAN |
Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date. Dr. Frohman has received publishing royalties from a publication relating to health care. |
| Cheryl Bushnell, MD, MHS |
The institution of Dr. Bushnell has received research support from PCORI. The institution of Dr. Bushnell has received research support from NIH/NINDS. Dr. Bushnell has received intellectual property interests from a discovery or technology relating to health care. Dr. Bushnell has received publishing royalties from a publication relating to health care. |
| David G. Brock, MD |
No disclosure on file
|
| Jeffrey L. Saver, MD, FAAN |
Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical. |
| Lewis P. Rowland, MD |
No disclosure on file
|
| Bruce L. Miller, MD, FAAN |
Dr. Miller has nothing to disclose. |
| Jacqueline French, MD, FAAN |
Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Praxis. Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Acadia Pharmaceuticals Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Access Industries that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Acuta Capital Partners LLC that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with AFASCI Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Agrithera, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Alkermes that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Angelini Pharma S.p.A. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Autifony Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Axonis Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bain Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Beacon Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biogen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Bloom Science, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bright Minds Biosciences, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Capsidia Biotherapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Cerevel that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, SAB with Cognizance Biomarkers that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ceribell that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cowen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with EcoR1 Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EG 427 that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant, Advisory Board with Eisai that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant/Advisory Board with Engrail that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EpiMinder that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Harmony that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Ionis Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with IQVIA that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Janssen Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Jazz Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, with Livanova that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with London Research & Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Longboard Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Maplight Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Marinus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Medscape/Web MD that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Montara Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Mosaica Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neumarker that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Neumirna Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neurelis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Neurocrine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neuropace that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neuroventis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neurona Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Neuvarti that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Noema that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ono Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Otsuka that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Ovid Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Praxis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LYT Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with QurAlis Corp that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Rapport Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Receptor Holdings, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rivervest Venture Partners that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Sage Therapeutics, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with SK Life Science that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stoke that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stream Neuroscience that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Takeda that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Taysha Gene Therapies that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with UCB, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with uniQure that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Ventus Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Xenon Pharmaceuticals that is relevant to AAN interests or activities. |
| Stephen D. Silberstein, MD, FAAN |
Dr. Silberstein has received publishing royalties from a publication relating to health care. |
| Hiroshi Mitsumoto, MD, FAAN |
Dr. Mitsumoto has nothing to disclose. |
| Bradley F. Boeve, MD, FAAN |
Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care. |
| Harold P. Adams, Jr., MD, FAAN |
The institution of Dr. Adams has received research support from NINDS. |
| Allen J. Aksamit, Jr., MD, FAAN |
Dr. Aksamit has nothing to disclose. |
| Bruce Brew, MD, MBBS, DSc, FAAN |
Dr. Brew has received intellectual property interests from a discovery or technology relating to health care. Dr. Brew has received publishing royalties from a publication relating to health care. Dr. Brew has received publishing royalties from a publication relating to health care. |
| David B. Clifford, MD, FAAN |
Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Excision BioTherapeutics. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seagen. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CellEvolve. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave Life Sciences. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeuitics. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity (Medpace). Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Clifford has received publishing royalties from a publication relating to health care. |
| R. E. Ramsay, MD |
Dr. Ramsay has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alliance Family of Companies. Dr. Ramsay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Ramsay has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Ramsay has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Ramsay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life Sci. |
| Joab Chapman, MD, PhD |
Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mapi Pharma. Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk Serono. The institution of Dr. Chapman has received research support from Ministry Of Industry. |
| Hamza I. Maqsood, MD |
Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. |
| Mark J. Alberts, MD, FAAN |
No disclosure on file
|
| Romergryko G. Geocadin, MD, FAAN |
Dr. Geocadin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Medicolegal Consulting. |
| Rohit Bakshi, MD, FAAN |
Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Bakshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimaging. The institution of Dr. Bakshi has received research support from Bristol Myers Squibb. The institution of Dr. Bakshi has received research support from EMD Serono. The institution of Dr. Bakshi has received research support from Novartis. |
| Peter W. Kaplan, MBBS, FRCP, FAAN |
Dr. Kaplan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for DNP Epiwatch. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for IFCN. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Kaplan has received publishing royalties from a publication relating to health care. |
| Dennis N. Bourdette, MD, FAAN |
Dr. Bourdette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Magellan Health Care. Dr. Bourdette has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctor's Inc. Dr. Bourdette has stock in Authobahn Therapeutics. Dr. Bourdette has received intellectual property interests from a discovery or technology relating to health care. |
| Joseph E. Parisi, MD |
Dr. Parisi has nothing to disclose. |
| Joseph F. Quinn, MD, FAAN |
Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Disease Cooperative Study. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Therapeutic Research Institute. Dr. Quinn has a non-compensated relationship as a consultant with Cognition Therapeutics that is relevant to AAN interests or activities. |
| Ilo Leppik, MD |
Dr. Leppik has nothing to disclose. |
| Anita L. Belman, MD, FAAN |
No disclosure on file
|
| Barry E. Gidal, PhD |
Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai . Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich. Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SK life sciences . Dr. Gidal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK life science . |
| David H. Miller, MD, MBChB, FRCP |
No disclosure on file
|
| David K. Simon, MD, PhD |
Dr. Simon has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Bial Biotech. An immediate family member of Dr. Simon has stock in Biogen. The institution of Dr. Simon has received research support from Weston Brain Institute. The institution of Dr. Simon has received research support from NIH. The institution of Dr. Simon has received research support from Neuraly. Dr. Simon has received personal compensation in the range of $5,000-$9,999 for serving as a Steering Committee Member: SPARK clinical study with Biogen. Dr. Simon has received personal compensation in the range of $500-$4,999 for serving as a Steering Committee Member: NILO-PD clinical study with Michael J Fox Foundation. |
| Israel Steiner, MD |
No disclosure on file
|
| Andrew R. Pachner, MD |
No disclosure on file
|
| Richard M. Ransohoff, MD |
Dr. Ransohoff has received personal compensation for serving as an employee of Third Rock Ventures. Dr. Ransohoff has stock in Biogen. Dr. Ransohoff has received intellectual property interests from a discovery or technology relating to health care. |
| Justin C. McArthur, MBBS, MPH, FAAN |
No disclosure on file
|
| Viken L. Babikian, MD, FAAN |
Dr. Babikian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Babikian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Baim Institute for Clinical Research. Dr. Babikian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. |
| James W. Schmidley, MD |
No disclosure on file
|
| Marc Fisher, MD, FAAN |
Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Fisher has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SimcereUSA. Dr. Fisher has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SimcereUSA. Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NoNo. Dr. Fisher has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. |
| John M. Pellock, MD |
No disclosure on file
|
| David S. Knopman, MD, FAAN |
Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH. |
| Robert M. Herndon, MD, FAAN |
No disclosure on file
|
| John A. Detre, MD |
Dr. Detre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hura Imaging. The institution of Dr. Detre has received research support from NIH. Dr. Detre has received personal compensation in the range of $500-$4,999 for serving as a grant proposal reviewer with NIH, VA, European Science Foundation,Deutsche Forschungsgemeinschaft. |
| Lawrence J. Hirsch, MD, FAAN |
Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceribell. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for marinus. The institution of Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport Therapeutics. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker; Faculty for Fellows' training course with Neuropace. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Natus. |
| Paul H. Gordon, MD, PhD, FAAN |
No disclosure on file
|
| James C. Cloyd, PharmD |
No disclosure on file
|
| Robert D. Brown, Jr., MD, MPH, FAAN |
Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Craig H Neilsen Foundation. The institution of Dr. Brown has received research support from National Institutes of Health/NINDS. Dr. Brown has received publishing royalties from a publication relating to health care. |
| David S. Goldstein, MD, PhD |
Dr. Goldstein has received publishing royalties from a publication relating to health care. |
| Gregory Krauss, MD |
Dr. Krauss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle. Dr. Krauss has received stock or an ownership interest from EpiWatch. |
| Beau M. Ances, MD, PhD, MS, FAAN |
Dr. Ances has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. |
| Stefan Schwab, MD |
Dr. Schwab has nothing to disclose. |
| Alan C. Jackson, MD, FAAN |
No disclosure on file
|
| May Han, MD |
Dr. Han has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Han has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arena Pharmaceuticals. |
| Nazli A. Janjua, MD, MBBS |
Dr. Janjua has nothing to disclose. |
| Michael D. Geschwind, MD, PhD, FAAN |
Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc.. |
| Dennis W. Dickson, MD |
Dr. Dickson has nothing to disclose. |
| Michael Hutton, PhD |
No disclosure on file
|
| Angela K. Birnbaum, PhD |
The institution of Dr. Birnbaum has received research support from National Institutes of Health. The institution of Dr. Birnbaum has received research support from Randy Shaver Cancer and Research Foundation. Dr. Birnbaum has received intellectual property interests from a discovery or technology relating to health care. |
| Avindra Nath, MD, MBBS, FAAN |
The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from Target ALS. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care. |
| Thomas C. Chelimsky, MD |
Dr. Chelimsky has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Proctor & Gamble. Dr. Chelimsky has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Various Legal Firms. Dr. Chelimsky has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various Legal Firms. Dr. Chelimsky has received stock or an ownership interest from PainSTakers, LLC. The institution of Dr. Chelimsky has received research support from NIDDK. The institution of Dr. Chelimsky has received research support from Advancing a Healthier Wisconsin. |
| Alan J. Thompson, MD, FRCP, FAAN |
No disclosure on file
|
| James A. Russell, DO, FAAN |
Dr. Russell has received publishing royalties from a publication relating to health care. |
| Matthew A. Koenig, MD |
No disclosure on file
|
| Cynthia Bodkin, MD, FAAN |
Dr. Bodkin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Bodkin has received research support from Massachusetts General Hospital. The institution of Dr. Bodkin has received research support from Alector LL. The institution of Dr. Bodkin has received research support from Atlantic research group. The institution of Dr. Bodkin has received research support from Amicus Therapeutics. The institution of Dr. Bodkin has received research support from Alexion. The institution of Dr. Bodkin has received research support from Anelixis. The institution of Dr. Bodkin has received research support from Medicinova INC. The institution of Dr. Bodkin has received research support from Ra Pharmaceuticals Inc. |
| Joel Gutierrez, MD |
Dr. Gutierrez has nothing to disclose. |
| Osman Kozak, MD |
No disclosure on file
|
| Anne M. Connolly, MD, FAAN |
Dr. Connolly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise Therapeutics. Dr. Connolly has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. Dr. Connolly has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Connolly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. The institution of Dr. Connolly has received research support from Muscular Dystrophy Association. The institution of Dr. Connolly has received research support from NIH. |
| Murray Grossman, MD, FAAN |
Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH. |
| Rakefet Tsabari, MD |
No disclosure on file
|
| Alireza Yarahmadi, MD |
No disclosure on file
|
| Kenneth L. Marek, MD |
Dr. Marek has received personal compensation for serving as an employee of IND. Dr. Marek has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for invicro. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for takeda. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Koneksa. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Xingimaging. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuron23. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Marek has received research support from Michael J Fox Foundation. |
| Donna L. Hill, MD |
No disclosure on file
|
| Erik K. St. Louis, MD |
The institution of Dr. St. Louis has received research support from NIH. Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care. |
| Keith A. Josephs, Jr., MD, FAAN |
Dr. Josephs has nothing to disclose. |
| Andrei V. Alexandrov, MD |
The institution of Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovaSignal. Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisc. Dr. Alexandrov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Alexandrov has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Society of Neuroimaging. Dr. Alexandrov has received publishing royalties from a publication relating to health care. |
| Saud Sadiq, BS, FAAN |
Ms. Brewi has nothing to disclose. |
| Imran I. Ali, MD, FAAN |
Dr. Ali has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. |
| Mary L. Zupanc, MD, FAAN |
Dr. Zupanc has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Praxis . Dr. Zupanc has received personal compensation in the range of $500-$4,999 for serving as a Chair of Review Committee for potential TSC grants with Department of Defense --CDRMC and PRMRP. Dr. Zupanc has a non-compensated relationship as a Board of Directors with Child Neurology Foundation that is relevant to AAN interests or activities. |
| Daniel Kantor, MD, FAAN |
Dr. Kantor has received personal compensation for serving as an employee of Gateway Institute for Brain Research. Dr. Kantor has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Kantor has a non-compensated relationship as a HAP with MSFous (MSF) that is relevant to AAN interests or activities. Dr. Kantor has a non-compensated relationship as a Medical Board with MS Views & News that is relevant to AAN interests or activities. |
| Fernando Cendes, MD, PhD, FAAN |
Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH. |
| Simone Appenzeller, PhD |
No disclosure on file
|
| Li M. Li, MD |
No disclosure on file
|
|
No disclosure on file
|
| Wei-Dong Le, MD, PhD |
No disclosure on file
|
| Anne E. Hammer |
No disclosure on file
|
| Erin Furr-Stimming, MD, FAAN |
Dr. Furr-Stimming has received personal compensation for serving as an employee of Help4HD International. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedPage. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Life Sciences. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Latus Bio. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atalanta Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SkyHawk Therapeutics. The institution of Dr. Furr-Stimming has received research support from Roche/Genetech. The institution of Dr. Furr-Stimming has received research support from Uniqure. The institution of Dr. Furr-Stimming has received research support from CHDI. The institution of Dr. Furr-Stimming has received research support from Huntington Study Group/Neurocrine Bioscienes. The institution of Dr. Furr-Stimming has received research support from NIH/University of Iowa. The institution of Dr. Furr-Stimming has received research support from HDSA. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has a non-compensated relationship as a Committee member with AAN UES Committee that is relevant to AAN interests or activities. |
| Mya C. Schiess, MD, FAAN |
Dr. Schiess has nothing to disclose. |
| Spyridon Papapetropoulos, MD, PhD |
Dr. Papapetropoulos has received personal compensation for serving as an employee of Vigil Neuroscience . Dr. Papapetropoulos has received personal compensation for serving as an employee of Bionomics Ltd. Dr. Papapetropoulos has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Lipocine Inc. Dr. Papapetropoulos has stock in Vigil Neuroscience. Dr. Papapetropoulos has stock in Lipocine. Dr. Papapetropoulos has stock in Bionomics Ltd. |
| Carlos Singer, MD |
Dr. Singer has nothing to disclose. |
| Mark S. LeDoux, MD, PhD |
No disclosure on file
|
| Pasquale Ferrante, MD |
No disclosure on file
|
| Keith R. Edwards, MD, FAAN |
No disclosure on file
|
| Andrew M. Demchuk, MD |
Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lumosa. Dr. Demchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer/BMS. Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim. Dr. Demchuk has received stock or an ownership interest from Circle NVI. Dr. Demchuk has received intellectual property interests from a discovery or technology relating to health care. |
| Anne Donnet, MD |
No disclosure on file
|
| Byung-Chul Lee, MD, PhD |
No disclosure on file
|
| Liang Lu, MD, FAAN |
Dr. Lu has nothing to disclose. |
| Peter H. King, MD |
The institution of Dr. King has received research support from Department of Veterans Affairs. The institution of Dr. King has received research support from NIH. |
| William T. Hu, MD, PhD, FAAN |
Dr. Hu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fujirebio. Dr. Hu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beckman Coulter. Dr. Hu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apellis Pharmaceuticals. The institution of Dr. Hu has received research support from NIA. The institution of Dr. Hu has received research support from TMCity Foundation. The institution of Dr. Hu has received research support from Atlanta Family Foundation. The institution of Dr. Hu has received research support from Fujirebio Diagnostics. |
| Martin J. Sadowski, MD, PhD |
The institution of Dr. Sadowski has received research support from National Institute on Aging. The institution of Dr. Sadowski has received research support from Biogen. The institution of Dr. Sadowski has received research support from Novartis. The institution of Dr. Sadowski has received research support from Janssen Research and Development. The institution of Dr. Sadowski has received research support from Eisai. The institution of Dr. Sadowski has received research support from TauRx Therapeutics Ltd. The institution of Dr. Sadowski has received research support from Suven Life Sciences Ltd.. The institution of Dr. Sadowski has received research support from Merck Sharp & Dohme Corp.. The institution of Dr. Sadowski has received research support from Alzheimer's Disease Cooperative Study. The institution of Dr. Sadowski has received research support from Neurotrack Technologies Inc.. Dr. Sadowski has received intellectual property interests from a discovery or technology relating to health care. Dr. Sadowski has received personal compensation in the range of $100,000-$499,999 for serving as a VA Physician with Veterans' Affairs. |
| Thomas M. Wisniewski, MD |
Dr. Wisniewski has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Aging Neuroscience. The institution of Dr. Wisniewski has received research support from the National Institute of Aging. Dr. Wisniewski has received intellectual property interests from a discovery or technology relating to health care. |
| Joanna Pankiewicz, MD, PhD |
No disclosure on file
|
| Joe Verghese, MD, FAAN |
Dr. Verghese has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedRhythms Inc. The institution of Dr. Verghese has received research support from National Institutes of Health. |
| Jaime Kulisevsky, MD, PhD |
Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Esteve. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Britannia. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Immune. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Britannia. |
| Ola A. Selnes, PhD |
No disclosure on file
|
| Ned C. Sacktor, MD, FAAN |
No disclosure on file
|
| Richard L. Skolasky, BA |
No disclosure on file
|
| Pierangelo Barbero, MD |
No disclosure on file
|
| Bruno Ferrero |
No disclosure on file
|
| Luca Durelli, MD |
No disclosure on file
|
| Marinella Clerico, MD |
Dr. Clerico has nothing to disclose. |
| OPTIMS Study Group |
No disclosure on file
|
| Maher Saqqur, MD |
Dr. Saqqur has nothing to disclose. |
| Aksel Siva, MD |
Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ali Raif Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanovel Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants. |
| Jan Mares, MD |
Dr. Mares has nothing to disclose. |
| Petr Kanovsky, PhD |
Dr. Kanovsky has nothing to disclose. |
| Hana Vranova, MD |
No disclosure on file
|
| Enrico Ferrante |
No disclosure on file
|
| Michael Schwarzschild, MD, PhD |
The institution of Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial Biotech (indirectly, as a service of the Parkinson Study Group service). The institution of Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen (indirectly, as a service of the Parkinson Study Group service). The institution of Dr. Schwarzschild has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB (indirectly, as a service of the Parkinson Study Group service). Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. The institution of Dr. Schwarzschild has received research support from NIH. The institution of Dr. Schwarzschild has received research support from Parkinson's Foundation. The institution of Dr. Schwarzschild has received research support from Michael J Fox Foundation. The institution of Dr. Schwarzschild has received research support from Farmer Family Foundation. Dr. Schwarzschild has a non-compensated relationship as a Chair, Executive Committee with the Parkinson Study Group that is relevant to AAN interests or activities. |
| Lawrence S. Honig, MD, PhD, FAAN |
Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Honig has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail. Dr. Honig has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cortexyme. Dr. Honig has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Firms . The institution of Dr. Honig has received research support from Roche. The institution of Dr. Honig has received research support from Eisau. Dr. Honig has received research support from Alector. The institution of Dr. Honig has received research support from Transposon. |
| Tianhong Pan, MD, PhD |
No disclosure on file
|
| Hans-Peter Hartung, MD, FAAN |
Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology. |
| Ja-Seong Koo, MD |
No disclosure on file
|
| Yunsook Jhang, MD |
No disclosure on file
|
| JiHoon Kang, MD, PhD |
No disclosure on file
|
| Jong-Moo Park, MD |
No disclosure on file
|
| Ohyun Kwon |
No disclosure on file
|
| Byung-kun Kim, MD |
Dr. Kim has nothing to disclose. |
| Mustapha A. Ezzeddine, MD, FAAN |
The institution of Dr. Ezzeddine has received research support from NIH. |
| Abu Nasar |
No disclosure on file
|
| Seo Hyun Kim, MD, PhD |
No disclosure on file
|
| Guillermo S. Garcia-Ramos, MD |
No disclosure on file
|
| Carlos Cantu, MD, MSc |
Dr. Cantu has nothing to disclose. |
| Aneesa I. Keya, MD |
No disclosure on file
|
| Charles R. Guttmann |
Charles R.G. Guttmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sintetica SA. Charles R.G. Guttmann has received stock or an ownership interest from Alnylam. Charles R.G. Guttmann has received stock or an ownership interest from Roche. Charles R.G. Guttmann has received stock or an ownership interest from Novartis. Charles R.G. Guttmann has received stock or an ownership interest from Arrowhead Pharmaceuticals. Charles R.G. Guttmann has received stock or an ownership interest from Protalix. Charles R.G. Guttmann has received stock or an ownership interest from Promethee. Charles R.G. Guttmann has received stock or an ownership interest from GSK. Charles R.G. Guttmann has received stock or an ownership interest from Sangamo. Charles R.G. Guttmann has received stock or an ownership interest from Alcon. Charles R.G. Guttmann has received stock or an ownership interest from Cocrystal Pharma. The institution of Charles R.G. Guttmann has received research support from NIH. The institution of Charles R.G. Guttmann has received research support from McGill University. The institution of Charles R.G. Guttmann has received research support from National Multiple Sclerosis Society. The institution of Charles R.G. Guttmann has received research support from BrightFocus Foundation. The institution of Charles R.G. Guttmann has received research support from National Multiple Sclerosis Society. The institution of Charles R.G. Guttmann has received research support from University of Connecticut Health Center. The institution of Charles R.G. Guttmann has received research support from U.S. Office of Naval Research. |
| Jeanne L. Beattie, MD |
No disclosure on file
|
| Shrikant Mishra, MD |
Dr. Mishra has nothing to disclose. |
| Julie H. Carter |
No disclosure on file
|
| Ashish Nanda, MD |
No disclosure on file
|
| Benjamin H. Eidelman, MB, FAAN |
Dr. Eidelman has nothing to disclose. |
| Carol Moore |
No disclosure on file
|
| Ramon R. Diaz-Arrastia, MD, PhD, FAAN |
Dr. Diaz-Arrastia has stock in BrainBox, LLC. Dr. Diaz-Arrastia has stock in Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense. |
| Caryn Harper |
No disclosure on file
|
| Marie-Germaine Bousser, MD |
No disclosure on file
|
| Nizar Souayah, MD, FAAN |
Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care. |
| Tarakad S. Ramachandran, MD, FAAN |
No disclosure on file
|
| Thomas L. Davis, MD |
Dr. Davis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Davis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Parkinson Foundation. |
| John Y. Fang, MD |
No disclosure on file
|
| Courtney Scott, MD |
Dr. Scott has nothing to disclose. |
| Frederick E. Munschauer III, MD, FAAN |
Dr. Munschauer has received personal compensation for serving as an employee of Emalex Biosciences. Dr. Munschauer has stock in Emalex Biosciences. |
| Neeta Garg, MD |
Dr. Garg has nothing to disclose. |
| Bianca Weinstock-Guttman, MD |
Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH. |
| Ajith Sominanda |
No disclosure on file
|
| Jan A. Hillert, MD |
Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Hillert has received research support from Biogen. The institution of Dr. Hillert has received research support from Celgene. The institution of Dr. Hillert has received research support from Merck. The institution of Dr. Hillert has received research support from Novartis. The institution of Dr. Hillert has received research support from Sanofi. The institution of Dr. Hillert has received research support from Roche. |
| Antonio Bertolotto, MD, FAAN |
Dr. Bertolotto has nothing to disclose. |
| Marco Capobianco, MD |
No disclosure on file
|
| Simona Malucchi |
No disclosure on file
|
| Alessia Di Sapio, MD |
No disclosure on file
|
| Francesca Gilli |
No disclosure on file
|
| Gavin Giovannoni, MD |
Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape. |
| M. F. Beal, MD |
No disclosure on file
|
| Mohammed A. Al-Jumah, MD, MBBS, FAAN |
No disclosure on file
|
| Enrico Marchioni |
Enrico Marchioni has nothing to disclose. |
| Bernhard Hemmer, MD |
No disclosure on file
|
| Stefan Nessler, MD |
No disclosure on file
|
| Sabine Cepok |
No disclosure on file
|
| Gloria Von Geldern, MD, FAAN |
The institution of Dr. Von Geldern has received research support from Novartis. The institution of Dr. Von Geldern has received research support from Contineum Therapeutics. Dr. Von Geldern has received personal compensation in the range of $0-$499 for serving as a DSMB member with NIH, NINDS. Dr. Von Geldern has a non-compensated relationship as a editorial board member with MS and Related Disorders Journal that is relevant to AAN interests or activities. |
| Rene Metz |
No disclosure on file
|
| Thomas McRae |
No disclosure on file
|
| Miri Y. Neufeld, MD |
No disclosure on file
|
| Oren S. Cohen, MD |
No disclosure on file
|
| Martin Nevrly, MD |
No disclosure on file
|
| Lilach Ephraty |
No disclosure on file
|
| Herman Buschke, MD |
No disclosure on file
|
| Oraporn Sitburana, MD |
No disclosure on file
|
| John G. Whitesides |
John G. Whitesides has received personal compensation for serving as an employee of UCB. John G. Whitesides has received stock or an ownership interest from UCB. |
| Ruta Mameniskiene, MD |
Dr. Mameniskiene has nothing to disclose. |
| Alain Vuong |
No disclosure on file
|
| John A. Messenheimer, Jr., MD |
Dr. Messenheimer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Zynerba Pharmaceuticals. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care. |
| Eleonora Tavazzi, MD |
No disclosure on file
|
| Stefano Bastianello |
No disclosure on file
|
| Scott L. Silliman, MD |
Dr. Silliman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. |
| Ana-Claire L. Meyer, MD, FAAN |
Dr. Meyer has received personal compensation for serving as an employee of Denali Therapeutics. |
| Jin J. Luo, MD, PhD, FAAN |
Dr. Luo has nothing to disclose. |
| Marcia F. Rupnow, PhD |
No disclosure on file
|
| Teresa Frohman, PA |
No disclosure on file
|
| Richard Buchsbaum |
No disclosure on file
|
| Haitham Hussein, MD, FAAN |
Dr. Hussein has nothing to disclose. |
| Joel J. Oger, MD, FRCPC, FAAN |
No disclosure on file
|
| Ebrima Gibbs, Bsc, BMLSc, MSc |
Dr. Gibbs has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Promis Neurosciences. |
| Alexander W. Dromerick, MD |
No disclosure on file
|
| John H. Growdon, MD |
No disclosure on file
|
| Kathryn O'Hara |
No disclosure on file
|
| Salvatore Napoli, MD |
Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for bristol myers. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for bristol myers. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for serono. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for eisai. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for vaccine injury. |
| Christian Stapf, MD |
No disclosure on file
|
| Hyman M. Schipper, MD, PhD, FAAN |
No disclosure on file
|
| Gennaro Bussone |
No disclosure on file
|
| Yousef Mohammad, MD |
No disclosure on file
|
| Nikolaos Scarmeas, MD, FAAN |
Dr. Scarmeas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Albert Einstein Collego of Medicine. The institution of Dr. Scarmeas has received research support from NovoNordisc. The institution of Dr. Scarmeas has received research support from European Union Horizon Projects. The institution of Dr. Scarmeas has received research support from Hellenic Foundation for Research & Innovation . |
| Violaine K. Harris, PhD |
No disclosure on file
|
| Elinor Ben-Menachem, MD, FAAN |
Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvelle. Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharma. Dr. Ben-Menachem has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Acta Neurologica Scandinvica. The institution of Dr. Ben-Menachem has received research support from zogenic. |
| Maria Rosario Luquin Piudo, MD |
No disclosure on file
|
| Waldy San Sebastian |
No disclosure on file
|
| Edith Durso-DeCruz, PhD |
No disclosure on file
|
| Alireza Atri, MD, PhD |
Dr. Atri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Prothena. Dr. Atri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. Dr. Atri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Atri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Atri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Atri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Life Molecular Imaging. Dr. Atri has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. Dr. Atri has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Atri has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lunbeck. Dr. Atri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ONO. Dr. Atri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Atri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AriBio. Dr. Atri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaxxinity. The institution of Dr. Atri has received research support from National Institute of Aging (NIA). The institution of Dr. Atri has received research support from AZ Department of Health Services. The institution of Dr. Atri has received research support from Gates Ventures. The institution of Dr. Atri has received research support from Multiple companies, universities & consortia for contracted clinical trials to institution. The institution of Dr. Atri has received research support from Washington University in St. Louis. The institution of Dr. Atri has received research support from Foundation for NIH. The institution of Dr. Atri has received research support from ACTC/NIH. Dr. Atri has received publishing royalties from a publication relating to health care. |
| Joan M. Ohayon |
Joan M. Ohayon has nothing to disclose. |
| Aissatou Haman |
No disclosure on file
|
| Timothy E. Lotze, MD, FAAN |
Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care. Dr. Lotze has received publishing royalties from a publication relating to health care. |
| Daniel Reich, MD, PhD |
Dr. Reich has received research support from NIH. The institution of Dr. Reich has received research support from Adelson Medical Research Foundation. The institution of Dr. Reich has received research support from Sanofi. The institution of Dr. Reich has received research support from Abata Therapeutics. The institution of Dr. Reich has received research support from National Multiple Sclerosis Society. The institution of Dr. Reich has received research support from Cure Alzheimer's Fund. Dr. Reich has received intellectual property interests from a discovery or technology relating to health care. Dr. Reich has received personal compensation in the range of $5,000-$9,999 for serving as a CME Faculty with Integrity. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Letters and Sciences. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Academic CME. Dr. Reich has a non-compensated relationship as a Advisor with Sanofi that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Board of Directors with ACTRIMS that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Abata Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with University of Basel RC2NB that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Multiple Sclerosis Society of Canada that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Tuscan Doctorate in Neuroscience that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Editorial Board with Multiple Sclerosis Journal that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Hyperfine that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Imaginab that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Annexon that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Philips that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Siemens that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Calico Life Sciences that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Cognito Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sudo that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Allumis that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with BioCentury that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Regeneron that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Eli Lilly that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with SetPoint that is relevant to AAN interests or activities. |
| Frauke Zipp, MD |
Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Zipp has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. The institution of Dr. Zipp has received research support from BMBF. The institution of Dr. Zipp has received research support from DFG. The institution of Dr. Zipp has received research support from PMSA. The institution of Dr. Zipp has received research support from Sanofi Genzyme. The institution of Dr. Zipp has received research support from UCB. The institution of Dr. Zipp has received research support from Eisai. The institution of Dr. Zipp has received research support from SK Life Science. The institution of Dr. Zipp has received research support from Abbott. The institution of Dr. Zipp has received research support from Actelion. The institution of Dr. Zipp has received research support from Bayer. The institution of Dr. Zipp has received research support from Servier. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with Novartis. Dr. Zipp has received personal compensation in the range of $0-$499 for serving as a Reviewer with Universite de Geneve. Dr. Zipp has received personal compensation in the range of $5,000-$9,999 for serving as a Reviewer with Oppenheim Förderpreis für Multiple Sklerose. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with EKFS. Dr. Zipp has a non-compensated relationship as a Associate Editor with Brain that is relevant to AAN interests or activities. Dr. Zipp has a non-compensated relationship as a Advisor with Science Translational Medicine that is relevant to AAN interests or activities. |
| Orhan Aktas, MD |
Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen/Horizon. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubish Tanake. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen/Horizon. The institution of Dr. Aktas has received research support from German Research Foundation. The institution of Dr. Aktas has received research support from German Ministry of Science. The institution of Dr. Aktas has received research support from Neuromyelitis optica Study Group (NEMOS). |
| Ulf Schulze Topphoff |
Ulf Schulze Topphoff has received personal compensation for serving as an employee of Novartis Pharma GmbH. |
| Stephanie J. Nahas, MD, FAAN |
Dr. Nahas has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for AbbVie. Dr. Nahas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Nahas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Nahas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Nahas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Nahas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch Health. Dr. Nahas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Nahas has received publishing royalties from a publication relating to health care. Dr. Nahas has received publishing royalties from a publication relating to health care. Dr. Nahas has received personal compensation in the range of $500-$4,999 for serving as a expert for CME activities with Medscape/WebMD. Dr. Nahas has a non-compensated relationship as a Board Member-at-Large with American Headache Society that is relevant to AAN interests or activities. Dr. Nahas has a non-compensated relationship as a Executive Board Member with The Headache Alliance that is relevant to AAN interests or activities. |
| Sean I. Savitz, MD |
Dr. Savitz has nothing to disclose. |
| John Gaitanis, MD |
No disclosure on file
|
| Ammar Al Kawi, MD, FAAN |
Dr. Al Kawi has nothing to disclose. |
| Dean K. Naritoku, MD, FAAN |
No disclosure on file
|
| Arthur Hays, MD |
No disclosure on file
|
| Valerie E. Wojna, MD, FAAN |
Dr. Wojna has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Puerto Rico Health Sciences Journal, University of Puerto Rico Medical Sciences Campus. The institution of Dr. Wojna has received research support from NIH. |
| John P. Seibyl, MD |
Dr. Seibyl has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Invicro. Dr. Seibyl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Seibyl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Life Molecular Imaging. Dr. Seibyl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Seibyl has received stock or an ownership interest from Invicro. |
| Paul Golumbek, MD, PhD |
No disclosure on file
|
| Jong S. Kim, MD, PhD |
No disclosure on file
|
| Sun U. Kwon, MD |
No disclosure on file
|
| Dong-wha Kang, MD |
No disclosure on file
|
| Oren Levy, MD |
Dr. Levy has received personal compensation for serving as an employee of Regeneron Pharmaceuticals . Dr. Levy has stock in Regeneron Pharmaceuticals . |
| Gillian Devereux |
No disclosure on file
|
| Benjamin Raudabaugh |
No disclosure on file
|
| Hiba A. Haider, MD |
Dr. Haider has received publishing royalties from a publication relating to health care. Dr. Haider has received publishing royalties from a publication relating to health care. |
| Jose L. Ruiz-Sandoval, MD |
Dr. Ruiz-Sandoval has nothing to disclose. |
| Erwin Chiquete, MD, PhD |
No disclosure on file
|
| Susan E. Goelz, PhD |
No disclosure on file
|
| Chellamani Harini, MD |
An immediate family member of Dr. Harini has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for abbvie. |
| Thorsten Eickenhorst, MD |
No disclosure on file
|
| Muhammad Taqi, MD |
No disclosure on file
|
| Alexandre Henri-Bhargava, MD |
No disclosure on file
|
| David G. Standaert, MD, PhD, FAAN |
Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie, Inc. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curium. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS/Pharmacy. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll Biopharma. Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for F. Hoffman LaRoche. Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Aventis. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance, Inc. Dr. Standaert has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorder Society. The institution of Dr. Standaert has received research support from Abbvie, Inc. The institution of Dr. Standaert has received research support from American Parkinson Disease Association. The institution of Dr. Standaert has received research support from National Institutes of Health. The institution of Dr. Standaert has received research support from F. Hoffman LaRoche. Dr. Standaert has received publishing royalties from a publication relating to health care. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with National Institutes of Health. Dr. Standaert has a non-compensated relationship as a Chair, Scientific Advisory Board with American Parkinson Disease Association that is relevant to AAN interests or activities. |
| Michelle Cameron, MD |
Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich Biosciences/Jazz . Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharmaceuticals. Dr. Cameron has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Cameron has received research support from National MS Society. The institution of Dr. Cameron has received research support from Department of Veterans Affairs. Dr. Cameron has received publishing royalties from a publication relating to health care. |
| Fay B. Horak, PhD |
No disclosure on file
|
| Nimish Thakore, MD |
No disclosure on file
|
| Roderick McColl, PhD |
No disclosure on file
|
| John M. Ringman, MD, FAAN |
The institution of Dr. Ringman has received research support from Avid Pharmaceuticals. The institution of Dr. Ringman has received research support from AltaMed. The institution of Dr. Ringman has received research support from CurePSP. |
| Muhammad A. Zaman-Khan, MD |
No disclosure on file
|
| Dennis L. Kolson, MD, PhD |
The institution of Dr. Kolson has received research support from NIH--R01 research grant. |
| Robert Beach, MD, PhD, FAAN |
The institution of Dr. Beach has received research support from Neurona. |
| David J. Nicholl, PhD, FRCP |
Dr. Nicholl has nothing to disclose. |
| Delphine Boerio, PhD |
No disclosure on file
|
| Jean-Pascal Lefaucheur |
No disclosure on file
|
| Alain Creange |
Alain Creange has nothing to disclose. |
| Mary Sano, PhD |
Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Avenir. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen Idec. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for BioXcel. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for CogRx. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Genentech. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for F. Hoffman LaRoche. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Minerva Neuroscience. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for NovoNordisk. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Pfizer. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for vTv Therapeutics. Dr. Sano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos. Dr. Sano has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Alzheimer's Association. Dr. Sano has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for International Psychogeriatric Association. |
| Michael G. Schlossmacher, MD |
No disclosure on file
|
| Lewis R. Sudarsky, MD |
No disclosure on file
|
| Lichuan Yang |
No disclosure on file
|
| Michael T. Lin, MD |
Dr. Lin has nothing to disclose. |
| Ippolita Cantuti-Castelvetri, PhD |
No disclosure on file
|
| Calvin A. Melmed, MD, FAAN |
No disclosure on file
|
| Diane M. Jacobs, PhD |
No disclosure on file
|
| Cenk Sengun, MD |
No disclosure on file
|
| Stanley J. Iyadurai, MD, PhD, FAAN |
Dr. Iyadurai has received personal compensation for serving as an employee of Catalyst Pharmaceuticals. Dr. Iyadurai has received stock or an ownership interest from Catalyst Pharmaceuticals. |
| Dalia Lorenzo, MD |
No disclosure on file
|
| Kevan E. VanLandingham, MD, PhD, FAAN |
Dr. VanLandingham has received personal compensation for serving as an employee of Greenwich Biosciences. Dr. VanLandingham has received stock or an ownership interest from Greenwich Biosciences. |
| Bruce A. Yankner, MD, PhD |
No disclosure on file
|
| Isak Prohovnik, PhD |
No disclosure on file
|
| Harold Moses, MD |
No disclosure on file
|
| Dirk Ulbricht, MD |
No disclosure on file
|
| Toshiki Takenouchi, MD |
No disclosure on file
|
| Dara G. Jamieson, MD |
Dr. Jamieson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Jamieson has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Medico-legal. Dr. Jamieson has received publishing royalties from a publication relating to health care. Dr. Jamieson has received personal compensation in the range of $100,000-$499,999 for serving as a Expert, Consultant with Health and Human Services, Department of Justice. |
| Ioannis Tsiropoulos, MD |
No disclosure on file
|
| Kyung-Hee Cho, MD |
No disclosure on file
|
| Alexandre Prat, MD |
The institution of Dr. Prat has received research support from CIHR and MSSC. |
| Amie W. Hsia, MD |
The institution of Dr. Hsia has received research support from NIH/NINDS. |
| Carissa Pineda, MD |
Dr. Pineda has nothing to disclose. |
| Ralf Reilmann, MD, FAAN |
The institution of Dr. Reilmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Reilmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for uniQure. The institution of Dr. Reilmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for WAVE. Dr. Reilmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for WAVE. The institution of Dr. Reilmann has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for IOS-Press. The institution of Dr. Reilmann has received research support from European Union. Dr. Reilmann has a non-compensated relationship as a Executive Committee Member with Huntington Study Group that is relevant to AAN interests or activities. Dr. Reilmann has a non-compensated relationship as a Member of Executive Committee with European Huntington Disease Network that is relevant to AAN interests or activities. Dr. Reilmann has a non-compensated relationship as a Co-Chair Task Force on Huntington Disease with Movement Disorders Socitey that is relevant to AAN interests or activities. |
| Ronel Santos, MD |
An immediate family member of Dr. Santos has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cochrane. Dr. Santos has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Giarmarco, Mullins & Horton PC. Dr. Santos has or had stock in Gilead Sciences.Dr. Santos has or had stock in Novocure.Dr. Santos has or had stock in Shockwave Medical.Dr. Santos has or had stock in Teva. An immediate family member of Dr. Santos has received research support from American Academy of Neurology. The institution of an immediate family member of Dr. Santos has received research support from Trinity Health Saint Mary's Foundation. An immediate family member of Dr. Santos has a non-compensated relationship as a Delegate with AAN Neurology on the Hill that is relevant to AAN interests or activities. An immediate family member of Dr. Santos has a non-compensated relationship as a Participant with AAN Palatucci Advocacy Leadership Forum that is relevant to AAN interests or activities. An immediate family member of Dr. Santos has a non-compensated relationship as a Scholar with AAN Health Equity Symposium Scholarship that is relevant to AAN interests or activities. An immediate family member of Dr. Santos has a non-compensated relationship as a Participant with AAN Emerging Leaders Program that is relevant to AAN interests or activities. |
| Barry A. Singer, MD |
Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TG Therapeutics. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb (Celgene). Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for EMD Serono. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Novartis. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Vanda. An immediate family member of Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Singer has received research support from Novartis. The institution of Dr. Singer has received research support from Sanofi. The institution of Dr. Singer has received research support from TG Therapeutics. The institution of Dr. Singer has received research support from Bristol Myers Squibb. |
| Kara S. Lewis, MD, FAAN |
Dr. Lewis has nothing to disclose. |
| Reina Benabou, MD, PhD |
No disclosure on file
|
| Ed Whalen |
Ed Whalen has received personal compensation for serving as an employee of Pfizer. Ed Whalen has stock in Pfizer. |
| Latha Ganti, MD, MS, MBA, FACEP |
Dr. Ganti has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Ganti has received publishing royalties from a publication relating to health care. |
| Wyatt W. Decker |
No disclosure on file
|
| Katayoun Vahedi, MD |
No disclosure on file
|
| Georgianna M. Richards, MD |
Dr. Richards has nothing to disclose. |
| Annapurni J. Trouth, MD, FAAN |
No disclosure on file
|
| Eric Edgar, MD |
No disclosure on file
|
| Kurt Lindsay, MD |
No disclosure on file
|
| George Perry, PhD |
Dr. Perry has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Synaptogenix. Dr. Perry has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE. Dr. Perry has stock in Synaptogenix. |
| Umberto De Girolami, MD |
No disclosure on file
|
| Dora Leung, MD |
Dr. Leung has stock in Doximity. Dr. Leung has stock in Johnson & Johnson. |
| Kamil Detyniecki, MD |
Dr. Detyniecki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aquestive. Dr. Detyniecki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Detyniecki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Detyniecki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich. |
| Muhammad S. Hussain, MD |
Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiger Medical. |
| Ali Al-Khathaami, MD |
No disclosure on file
|
| Helen Tremlett, PhD, BPharm |
Dr. Tremlett has nothing to disclose. |
| Hector R. Martinez, MD |
Dr. Martinez has nothing to disclose. |
| Joseph Maytal, MD |
No disclosure on file
|
| Ricardo C. Reisin, MD |
Dr. Reisin has nothing to disclose. |
| Mario Savoiardo, MD |
No disclosure on file
|
| Richard D. Jacobson, MD, PhD |
No disclosure on file
|
| Steven W. Johnson, MD, PhD |
No disclosure on file
|
| Stella M. Papa, MD |
No disclosure on file
|
| Alejandro R. Marfil-Rivera, MD |
Dr. Marfil-Rivera has nothing to disclose. |
| Mohammad Wasay, MBBS, FAAN |
Dr. Wasay has nothing to disclose. |
| Bashir S. Shihabuddin, MD |
No disclosure on file
|
| Susan M. Staugaitis, MD, PhD |
No disclosure on file
|
| Giorgio Meneghetti, MD |
No disclosure on file
|
| Paolo Barone, MD |
No disclosure on file
|
| Michael D. Devous, Sr., PhD |
No disclosure on file
|
| Farzaneh A. Sorond, MD, PhD |
Dr. Sorond has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Sorond has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. The institution of Dr. Sorond has received research support from NIH. |
| Ted ONeil |
No disclosure on file
|
| Giorgio Giuliani, MD |
No disclosure on file
|
| Enrico Montanari |
No disclosure on file
|
| Vladimir Chistik |
No disclosure on file
|
| Juan Jose Quintana, MD |
No disclosure on file
|
| Nils Koch-Henriksen, MD |
Dr. Koch-Henriksen has nothing to disclose. |
| Elias A. Giraldo, MD, MS, FAAN |
Dr. Giraldo has nothing to disclose. |
| Graham J. Schapel, MD |
No disclosure on file
|
| Peter Ostrow, MD |
No disclosure on file
|
| Clemens R. Scherzer, MD |
Dr. Scherzer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Scherzer has received research support from NIH. The institution of Dr. Scherzer has received research support from Michael J. Fox Foundation. The institution of Dr. Scherzer has received research support from American Parkinson's Disease Association. Dr. Scherzer has received intellectual property interests from a discovery or technology relating to health care. |
| Massimo Del Sette |
No disclosure on file
|
| Daniel Rabinovitch, MD |
No disclosure on file
|
| Ian McKeith |
No disclosure on file
|
| Jaume Roquer Gonzalez |
No disclosure on file
|
| Carla Zanferrari |
No disclosure on file
|
| Alessandro Adami |
Alessandro Adami has nothing to disclose. |
| Aase D. Mygland, MD |
No disclosure on file
|
| Pablo Bonardo, MD |
Dr. Bonardo has nothing to disclose. |
| Charo Luquin |
No disclosure on file
|
| Heather S. Conklin |
No disclosure on file
|
| Cristin McKenna |
No disclosure on file
|
| Craig J. Gardner, DO |
No disclosure on file
|
| Atchayaram Nalini, MBBS |
No disclosure on file
|
| Amy E. Sanders, MD, FAAN |
Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Adlarity. Dr. Sanders has a non-compensated relationship as a Medical and Scientific Advisory Board with Alzheimer's Association (CT Chapter) that is relevant to AAN interests or activities. Dr. Sanders has a non-compensated relationship as a Board Member with UCNS that is relevant to AAN interests or activities. |
| Joseph D. Burns, MD |
Dr. Burns has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. |
| Irene J. Oh, MD |
No disclosure on file
|
| Stephanie Lessig, MD |
No disclosure on file
|
| Rachel A. Farrell, MD |
The institution of Dr. Farrell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharma / Jazz. The institution of Dr. Farrell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. |
| Hideki Mochizuki, MD |
No disclosure on file
|
| Juan M. Escamilla, MD |
No disclosure on file
|
| Rebecca Spain, MD, MSPH, FAAN |
Dr. Spain has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for United States Department of Justice. The institution of Dr. Spain has received research support from Department of Veterans Affairs. The institution of Dr. Spain has received research support from National Multiple Sclerosis Society. |
| Lakshmi N. Ranganathan, MD, PhD, FAAN |
Dr. Ranganathan has nothing to disclose. |
| Philippe Huot, MD |
No disclosure on file
|
| Alejandro Tobon, MD, FAAN |
Dr. Tobon has nothing to disclose. |
| Jonathan H. McKinnon, MD |
No disclosure on file
|
| Joe Hirsch |
No disclosure on file
|
| Leonel Cantu-Martinez, MD |
Dr. Cantu-Martinez has nothing to disclose. |
| Farhan Siddiq, MD |
Dr. Siddiq has nothing to disclose. |
| Patricia Krief, MD |
No disclosure on file
|
| Berneet Kaur, MD |
No disclosure on file
|
| Elizabeth H. Morrison-Banks, MD, MSEd |
Dr. Morrison-Banks has nothing to disclose. |
| Leigh Ramos-Platt, MD, MBA |
Dr. Ramos-Platt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. The institution of Dr. Ramos-Platt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Ramos-Platt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cure sma. Dr. Ramos-Platt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Ramos-Platt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Catalyst. Dr. Ramos-Platt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MyTomorrows. |
| Unn Ljostad, MD, PhD |
No disclosure on file
|
| Abdul Salam Al Soliman, MSc |
No disclosure on file
|
| Zohara Sternberg, PhD |
No disclosure on file
|
| Thomas Engberg |
No disclosure on file
|
| Michael DeCuypere |
No disclosure on file
|
| Iraj Nikfarjam, MD |
No disclosure on file
|
| Deren Huang, MD |
Dr. Huang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Huang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. |
| Maria Assuncao Tuna, MD |
No disclosure on file
|
| San Jung, MD |
No disclosure on file
|
| Swaraj Singh, MD |
No disclosure on file
|
| Scott J. Stevens, MD |
No disclosure on file
|
| Daniela Perani, MD |
No disclosure on file
|
| Lesley M. Arnold, MD |
No disclosure on file
|
| Eitan Auriel |
No disclosure on file
|
| Tariq M. Aziz |
No disclosure on file
|
| M. Fernanda Bellolio, MD |
No disclosure on file
|
| Oladi S. Bentho, MD |
Dr. Bentho has nothing to disclose. |
| Maxime Berube-Desrosiers, MD |
Dr. Berube-Desrosiers has nothing to disclose. |
| Melissa Brock |
Melissa Brock has nothing to disclose. |
| Xuebing Cao, MD, PhD |
No disclosure on file
|
| Rudolph Castellani |
No disclosure on file
|
| Luisa Chiapparini, MD |
No disclosure on file
|
| Joanne Clark |
No disclosure on file
|
| Scott Davis, PhD |
No disclosure on file
|
| Meghan McGoldrick |
No disclosure on file
|
| Dilesh Doshi, PharmD |
Dr. Doshi has received personal compensation for serving as an employee of Acadia Pharmaceuticals. |
| Michael Douglas, MD |
No disclosure on file
|
| David Gaist, MD |
Dr. Gaist has nothing to disclose. |
| Sabih Effendi |
No disclosure on file
|
| Sailaja Enduri, MD |
No disclosure on file
|
| Robert J. Fischer, MD |
No disclosure on file
|
| Georgios Tsivgoulis, MD, FAAN |
Dr. Tsivgoulis has nothing to disclose. |
| Leonid Gorelik, PhD |
No disclosure on file
|
| Elizabeth Goy, PhD |
No disclosure on file
|
| Cara Heers, PhD |
No disclosure on file
|
| Nils Henninger, MD, PhD, FANA, FWSO |
Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Henninger has stock in United Health. Dr. Henninger has stock in Novo Nordisk. Dr. Henninger has stock in Elli Lilly. Dr. Henninger has stock in Kenvue. Dr. Henninger has stock in Voyager. Dr. Henninger has stock in Alnylam. Dr. Henninger has stock in Entrada. The institution of Dr. Henninger has received research support from NIH. Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Verge Genomics. |
| Beth Hochman |
No disclosure on file
|
| Ann Hoff |
No disclosure on file
|
| David Irwin, MD |
The institution of Dr. Irwin has received research support from NIH. The institution of Dr. Irwin has received research support from Prevail. The institution of Dr. Irwin has received research support from Passage Bio. The institution of Dr. Irwin has received research support from Alector. The institution of Dr. Irwin has received research support from Transposon. The institution of Dr. Irwin has received research support from Denali. The institution of Dr. Irwin has received research support from Cervo Med. |
| Pornpimol Kijsanayotin |
No disclosure on file
|
| Jung-Ju Lee, MD, PhD |
No disclosure on file
|
| Justin Thorson, MD |
Dr. Thorson has nothing to disclose. |
| Zhixiang Liao |
No disclosure on file
|
| Robert F. Lopez-Alberola, MD |
Dr. Lopez-Alberola has nothing to disclose. |
| Bindu Menon, MD, MBBS, FAAN |
Dr. Menon has nothing to disclose. |
| Simin Mansoor, MD |
No disclosure on file
|
| Gabriel M. Napoli, MD |
Dr. Napoli has nothing to disclose. |
| Mi Sun Oh |
No disclosure on file
|
| Mai Yamakawa, MD |
Dr. Yamakawa has nothing to disclose. |
| Kimberly G. Peters, MD |
No disclosure on file
|
| Guy Poloni, PhD |
No disclosure on file
|
| Michael Potchen |
No disclosure on file
|
| Luis D. Medina, PhD |
The institution of Dr. Medina has received research support from National Institutes of Health. Dr. Medina has received personal compensation in the range of $500-$4,999 for serving as a Speaker with AbbVie. Dr. Medina has a non-compensated relationship as a Council Member with Alzheimer's Association that is relevant to AAN interests or activities. |
| Rushabh Modi |
No disclosure on file
|
| Julieta V. Mazziotti, MD |
No disclosure on file
|
| Susan Marino, PhD |
No disclosure on file
|
| Juan Jose Martinez-Padilla |
No disclosure on file
|
| Anne C. Roc, PhD |
No disclosure on file
|
| Gianluca Rossato |
No disclosure on file
|
| I. Jon Russell |
No disclosure on file
|
| Zulema Salazar Salazar, MD |
Dr. Salazar Salazar has nothing to disclose. |
| Christopher Schwan |
No disclosure on file
|
| Charles Torres-Chae |
No disclosure on file
|
| Sophia Wang |
No disclosure on file
|
| Yasumasa Yamamoto |
Yasumasa Yamamoto has nothing to disclose. |
| Henrik Zetterberg |
Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, Acumen, Alector, Alzinova, ALZpath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Quanterix, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alzecure, BioArctic, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, Roche, and WebMD. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley and Elsevier. Henrik Zetterberg has stock in Brain Biomarker Solutions. |
| Yu Zhao, MD |
No disclosure on file
|
| Bin Zheng, PhD |
No disclosure on file
|
| Wen Zhu |
No disclosure on file
|
| Molly Zimmerman |
No disclosure on file
|
| Duarte G. Machado, MD, FAAN |
Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. |
| Carrie E. Robertson, MD, FAAN |
Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Linpharma. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satsuma. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apeya. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Robertson has received research support from Biohaven/Pfizer. Dr. Robertson has received publishing royalties from a publication relating to health care. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Research consultant with University of Minnesota. |
| Sandro Iannaccone |
No disclosure on file
|
| Gregory S. Aaen, MD |
Dr. Aaen has nothing to disclose. |
| Shaukat Ali, MD |
No disclosure on file
|
| Mark Gorman, MD |
The institution of Dr. Gorman has received research support from Pfizer. The institution of Dr. Gorman has received research support from Roche / Genetech . |
| Judy Illes, PhD, OC |
Dr. Illes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stanford University. Dr. Illes has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier Press. The institution of Dr. Illes has received research support from NIH, CIHR, North Family Foundation, FRQ. Dr. Illes has received publishing royalties from a publication relating to health care. Dr. Illes has a non-compensated relationship as a Distinguished University Professor and Distinguished Professor in Neuroethics with University of British Columbia that is relevant to AAN interests or activities. |
| Corey McMillan, PhD |
Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. McMillan has received research support from Biogen. The institution of Dr. McMillan has received research support from NIH. |
| Sarah Song, MD, MPH, FAAN |
Dr. Song has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. |
| Sana Syed, MD |
Dr. Syed has received personal compensation for serving as an employee of Sanofi US. |
| Zongqi Xia, MD, PhD |
The institution of Dr. Xia has received research support from National Institute of Health. The institution of Dr. Xia has received research support from Genentech/Roche. |
| Soojin Park, MD |
Dr. Park has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical Care. The institution of Dr. Park has received research support from National Institutes of Health. |
| Sachin Agarwal, MD, MPH |
Dr. Agarwal has nothing to disclose. |
| Lori Chibnik |
No disclosure on file
|
| Irene Cortese, MD |
Dr. Cortese has stock in Keires, AG. Dr. Cortese has stock in Nouscom, AG. Dr. Cortese has stock in PDC*line Pharma. |
| Jennifer Graves, MD, PhD |
Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono. |
| Charles Maitland |
No disclosure on file
|
| Soe S. Mar, MD, FAAN |
The institution of Dr. Mar has received research support from NIH. |
| Takashi Kanda, MD |
Dr. Kanda has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Igaku-shoin Ltd.. |
| Louis C. Tan, MRCP |
No disclosure on file
|
| Yasuteru Sano, MD |
No disclosure on file
|
| Katharina M. Busl, MD, MS, FAAN |
Dr. Busl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Rissman Law. Dr. Busl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Huffman Powell Baley. Dr. Busl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for University Science. Dr. Busl has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SCCM. Dr. Busl has a non-compensated relationship as a Board Member with Art in Medicine that is relevant to AAN interests or activities. Dr. Busl has a non-compensated relationship as a Associate Editor with Critical Care Explorations that is relevant to AAN interests or activities. Dr. Busl has a non-compensated relationship as a Assistant Editor with Neurocritical Care that is relevant to AAN interests or activities. |
| Leslie A. Benson, MD |
The institution of Dr. Benson has received research support from ROHHAD Fight, Inc. The institution of Dr. Benson has received research support from NIH. The institution of Dr. Benson has received research support from Roche/Genentech. Dr. Benson has received personal compensation in the range of $0-$499 for serving as a consultant with MA Department of public health. Dr. Benson has received personal compensation in the range of $10,000-$49,999 for serving as a consultant with National vaccine injury compensation program. |
| Sumit Verma, MD |
Dr. Verma has nothing to disclose. |
| Kavit Shah, MD |
Dr. Shah has nothing to disclose. |
| AGADI J. B, MD, FAAN |
No disclosure on file
|
| Damiano Baroncini |
No disclosure on file
|
| Shivani Ghoshal, MD |
Dr. Ghoshal has nothing to disclose. |
| Kaavya Narasimhalu, MD, PhD |
No disclosure on file
|
| Teresa Wu, MD |
No disclosure on file
|
| A A. Leis, MD, FAAN |
No disclosure on file
|
| Alon Seifan, MD |
Dr. Seifan has received personal compensation in the range of $100,000-$499,999 for serving as a Chief Science Officer with HB Biotech. |
| Michelle P. Kvalsund, DO |
Dr. Kvalsund has nothing to disclose. |
| Catherine Maurice, MD |
No disclosure on file
|
| Laurel J. Cherian, MD, FAAN |
The institution of Dr. Cherian has received research support from NIH. |
| Natarajan Visvanathan, MD, DM, FAAN |
No disclosure on file
|
| Stephen J. Tapscott, MD, PhD |
Dr. Tapscott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Tapscott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fulcrum Therapeutics. Dr. Tapscott has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kate Therapeutics. Dr. Tapscott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for miRecule. Dr. Tapscott has received intellectual property interests from a discovery or technology relating to health care. |
| Yuebing Li, MD, PhD, FAAN |
Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex. The institution of Dr. Li has received research support from Argenx. |
| Federico E. Micheli, MD |
No disclosure on file
|
| Gabriela Raina |
No disclosure on file
|
| Bhavesh Trikamji, MD |
Dr. Trikamji has nothing to disclose. |
| Janace Hart |
No disclosure on file
|
| Luis Pellene |
Luis Pellene has nothing to disclose. |
| Tom Solomon |
No disclosure on file
|
| Farhaan S. Vahidy, MBBS, PhD |
Dr. Vahidy has nothing to disclose. |
| Ciro Ramos Estebanez, MD, PhD, MBA, FAAN |
The institution of Dr. Ramos Estebanez has received research support from NIH. Dr. Ramos Estebanez has received intellectual property interests from a discovery or technology relating to health care. |
| Mary Jane Lim-Fat, MD, FRCPC |
Dr. Lim Fat has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Lim Fat has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Lim Fat has received research support from Brain Cancer Canada. |
| Radha Mahadevan, MD |
No disclosure on file
|
| Julia Zhu, MD |
No disclosure on file
|
| Johanna Hamel, MD |
Dr. Hamel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. |
| Manav Vyas, MD |
The institution of Dr. Vyas has received research support from Heart and Stroke Foundation of Canada . The institution of Dr. Vyas has received research support from Canadian Institutes of Health Research . Dr. Vyas has received research support from Heart and Stroke Foundation of Canada . |
| Sarah J. Banks, PhD |
No disclosure on file
|
| Katelyn S. Kavak |
Ms. Kavak has nothing to disclose. |
| Soma Sahai-Srivastava, MD |
No disclosure on file
|
| Artemio A. Roxas, Jr., MD |
Dr. Roxas has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis Philippines. |
| Jenny Z. Lin, MD |
No disclosure on file
|
| Jacob A. Sloane, MD, PhD |
Dr. Sloane has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for biogen. Dr. Sloane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Sloane has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. |
| Silvia Folgar, MD |
No disclosure on file
|
| Naser Alotaibi, MD |
Dr. Alotaibi has nothing to disclose. |
| William R. Meador, MD |
Dr. Meador has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for ForensisGroup. The institution of Dr. Meador has received research support from PCORI. The institution of Dr. Meador has received research support from ROCHE/GENENTECH. |
| Serge Belinga, MD |
No disclosure on file
|
| Babak Rezaei, MD |
No disclosure on file
|
| Esther Melamed, MD, PhD |
Dr. Melamed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Melamed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Melamed has received research support from NIH. The institution of Dr. Melamed has received research support from Babson Diagnostics. The institution of Dr. Melamed has received research support from Austin Public Health. |
| Cristian Calandra, MD |
Dr. Calandra has nothing to disclose. |
| Mutharasu Chinnu, MD |
No disclosure on file
|
| Krishna Nalleballe, MD, FAAN |
Dr. Nalleballe has nothing to disclose. |
| Namir Khandker, MD |
No disclosure on file
|
| Addie Peretz, MD |
Dr. Peretz has nothing to disclose. |
| LORENA TSCHOPP, MD |
No disclosure on file
|
| Ishan Adhikari, MD, FAAN |
No disclosure on file
|
| Varun Shandal, MD |
Dr. Shandal has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for The Killino Firm, P.C.. |
| Sarita W. Maturu, MD |
Dr. Maturu has nothing to disclose. |
| Ashutosh Kumar, MD |
Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC therapeutics. Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Kumar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PTC therapeutics. Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American Academy of Pediatrics. The institution of Dr. Kumar has received research support from PTC therapeutics. The institution of Dr. Kumar has received research support from Sarepta Therapeutics. The institution of Dr. Kumar has received research support from Novartis/Avexis. The institution of Dr. Kumar has received research support from Fibrogen . The institution of Dr. Kumar has received research support from Biohaven. The institution of Dr. Kumar has received research support from Genentech. The institution of Dr. Kumar has received research support from MDA. Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as a Draft Report Reviewer/consultant with ECRI/Atheneum/QTC commercial services LLC/Connected Research and consulting/Vox.Bio. |
| Jessica Magid-Bernstein, MD, PhD |
Dr. Magid-Bernstein has nothing to disclose. |
| Ankur Doshi |
No disclosure on file
|
| Ilena George, MD |
The institution of Dr. George has received research support from Biogen. |
| Mosunmola Oyawusi, MD |
Dr. Oyawusi has nothing to disclose. |
| Yukio Takeshita, MD, PhD |
No disclosure on file
|
| Brandi L. Vollmer, MPH |
Ms. Vollmer has nothing to disclose. |
| Veronica A. Tkachuk |
Veronica A. Tkachuk has nothing to disclose. |
| Robert Valuck |
No disclosure on file
|
| Heidemarie Lex, PhD |
No disclosure on file
|
| Jong Yun Lee |
No disclosure on file
|
| Tenzin Choezom |
No disclosure on file
|
| Shiliang Zhang |
No disclosure on file
|
| Hitten Zaveri |
No disclosure on file
|
| Sreya Radhakrishna, MD |
Dr. Radhakrishna has nothing to disclose. |
| Angela C. Gauthier |
No disclosure on file
|
| Rasesh Joshi, MD, PhD |
No disclosure on file
|
| Mohammed Alskaini, Jr., MD |
No disclosure on file
|
| Ayman Al Jurdi |
No disclosure on file
|
| Hadi Maghzi, MD |
No disclosure on file
|
| Romaine Schubert, MD |
No disclosure on file
|
| Maria G. Cersosimo, MD |
No disclosure on file
|
| Janice M. Buelow, PhD, RN |
No disclosure on file
|
| Gabrielle M. Horstman, MD |
No disclosure on file
|
| Meghan Candee, MD |
Dr. Candee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Finn Partners Marketing. |
| Neville A. Schepmyer, MD |
No disclosure on file
|
| Hunan A. Chaudhry, MD |
No disclosure on file
|
| Victoria A. Ebiana, MD |
No disclosure on file
|
| Tiffany Cossey, MD |
Dr. Cossey has nothing to disclose. |
| Ilana L. Kahn, MD |
Dr. Kahn has nothing to disclose. |
| Ricardo Maiola, MD |
No disclosure on file
|
| Mathes Burke |
No disclosure on file
|
| Derek W. Stitt, MD |
Dr. Stitt has nothing to disclose. |
| ORHAN YILMAZ |
No disclosure on file
|
| Vishakhadatta Mathur Kumaraswamy, MD |
The institution of Dr. Mathur Kumaraswamy has received research support from Woolsey Pharmaceuticals. |
| Tarun Girotra, MD |
Dr. Girotra has nothing to disclose. |
| Cynthia Garcia Fernandez |
No disclosure on file
|
| Fernando Auvieux Arias |
No disclosure on file
|
| Shelly Benjaminy |
No disclosure on file
|
| Shima Bozorgui, MD |
Dr. Bozorgui has nothing to disclose. |
| Alessandra Cardi |
No disclosure on file
|
| Jonathan Elmer |
Jonathan Elmer has received publishing royalties from a publication relating to health care. |
| Heng Nhoung |
No disclosure on file
|
| Stefan Sillau |
Stefan Sillau has nothing to disclose. |